Most people don't have the time to thoroughly research cannabis stocks, nor the experience to know when to buy or sell - this is where CST comes in.
We give everyday traders the opportunity to look over the shoulder of an equities analyst with a passion for the cannabis sector.
Members of CST get daily analysis and access to a model portfolio so they can review cannabis investments like a pro.
Leading The Way
Michael Vodicka is a globally syndicated equity analyst with more than 20 years of experience in trading and investing. His research has been featured in some of the industry’s most respected publications.
He has been investing and leading investors in the cannabis sector since 2013. Now, Mr. Vodicka brings his expertise and guidance to the members of Cannabis Stock Trades.
It looks like France’s Constitutional Council is giving CBD its blessing, saying that CBD is not harmful to health nor addictive. This contradicts a December decree which prohibited the possession, use, or sale of CBD. Continue “France’s Constitutional Council Gives CBD the Nod”
Tilray, Inc. (TLRY), now Tilray Brands, Inc., announced good news during its Q2 fiscal 2022 earnings call.
CEO Irwin Simon applauded Tilray’s ability to maintain status with the #1 cannabis market share in Canada. In addition, he said, “Our second quarter performance reflects notable success building high-quality and highly sought-after cannabis and lifestyle CPG brands.”Continue “Tilray Maintains #1 Position in Canada”
A recent study by Oregon State University (OSU) and Oregon Health and Science University uncovered two chemicals that may protect human cells from COVID-19 infections. These chemicals are found in live cannabis plants. Continue “Can Cannabis Help Fight COVID?”
